We used IGF-1 level to diagnose GHD at follow-up, as earlier studies have shown that a low IGF-1 level reliably predicts GHD among survivors of radiotherapy-treated childhood brain tumor [33, 34]. This evidence concerns the gene IGF1 and brain neoplasm.